Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_assertion type Assertion NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_head.
- NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_assertion description "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_provenance.
- NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_assertion evidence source_evidence_literature NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_provenance.
- NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_assertion SIO_000772 16803511 NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_provenance.
- NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_assertion wasDerivedFrom befree-20140225 NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_provenance.
- NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_assertion wasGeneratedBy ECO_0000203 NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_provenance.